“NMR Metabolic Fingerprint of Bevacizumab in Mutant IDH1 Glioma Cells”. Radiology and Oncology 52, no. 4 (December 17, 2018). Accessed September 22, 2026. https://www.radioloncol.com/index.php/ro/article/view/2963.